A citation-based method for searching scientific literature

Katja Thümmler, Eran Rom, Thomas Zeis, Maren Lindner, Sarah Brunner, John J Cole, Diana Arseni, Steve Mücklisch, Julia M Edgar, Nicole Schaeren-Wiemers, Avner Yayon, Christopher Linington. Acta Neuropathol Commun 2019
Times Cited: 8







List of co-cited articles
70 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
Xavier Montalban, Stephen L Hauser, Ludwig Kappos, Douglas L Arnold, Amit Bar-Or, Giancarlo Comi, Jérôme de Seze, Gavin Giovannoni, Hans-Peter Hartung, Bernhard Hemmer,[...]. N Engl J Med 2017
742
37


Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients.
Paola Sarchielli, Massimiliano Di Filippo, Maria Vittoria Ercolani, Davide Chiasserini, Alessia Mattioni, Michele Bonucci, Serena Tenaglia, Paolo Eusebi, Paolo Calabresi. Neurosci Lett 2008
43
37


The relation between inflammation and neurodegeneration in multiple sclerosis brains.
Josa M Frischer, Stephan Bramow, Assunta Dal-Bianco, Claudia F Lucchinetti, Helmut Rauschka, Manfred Schmidbauer, Henning Laursen, Per Soelberg Sorensen, Hans Lassmann. Brain 2009
826
37

Multiple sclerosis: experimental models and reality.
Hans Lassmann, Monika Bradl. Acta Neuropathol 2017
215
37

FGF-2 and Anosmin-1 are selectively expressed in different types of multiple sclerosis lesions.
Diego Clemente, María Cristina Ortega, Francisco Javier Arenzana, Fernando de Castro. J Neurosci 2011
75
37

Fibroblast growth factor-2 signaling in neurogenesis and neurodegeneration.
Maya E Woodbury, Tsuneya Ikezu. J Neuroimmune Pharmacol 2014
116
25

M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination.
Veronique E Miron, Amanda Boyd, Jing-Wei Zhao, Tracy J Yuen, Julia M Ruckh, Jennifer L Shadrach, Peter van Wijngaarden, Amy J Wagers, Anna Williams, Robin J M Franklin,[...]. Nat Neurosci 2013
914
25

Demyelination versus remyelination in progressive multiple sclerosis.
Stephan Bramow, Josa M Frischer, Hans Lassmann, Nils Koch-Henriksen, Claudia F Lucchinetti, Per S Sørensen, Henning Laursen. Brain 2010
173
25

Cellular senescence in progenitor cells contributes to diminished remyelination potential in progressive multiple sclerosis.
Alexandra M Nicaise, Laura J Wagstaff, Cory M Willis, Carolyn Paisie, Harshpreet Chandok, Paul Robson, Valentina Fossati, Anna Williams, Stephen J Crocker. Proc Natl Acad Sci U S A 2019
74
25

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.
Ludwig Kappos, Amit Bar-Or, Bruce A C Cree, Robert J Fox, Gavin Giovannoni, Ralf Gold, Patrick Vermersch, Douglas L Arnold, Sophie Arnould, Tatiana Scherz,[...]. Lancet 2018
338
25

Metformin Restores CNS Remyelination Capacity by Rejuvenating Aged Stem Cells.
Björn Neumann, Roey Baror, Chao Zhao, Michael Segel, Sabine Dietmann, Khalil S Rawji, Sarah Foerster, Crystal R McClain, Kevin Chalut, Peter van Wijngaarden,[...]. Cell Stem Cell 2019
85
25


NG2 glia generate new oligodendrocytes but few astrocytes in a murine experimental autoimmune encephalomyelitis model of demyelinating disease.
Richa B Tripathi, Leanne E Rivers, Kaylene M Young, Francoise Jamen, William D Richardson. J Neurosci 2010
169
25

Central nervous system regeneration is driven by microglia necroptosis and repopulation.
Amy F Lloyd, Claire L Davies, Rebecca K Holloway, Yasmine Labrak, Graeme Ireland, Dario Carradori, Alessandra Dillenburg, Eva Borger, Daniel Soong, Jill C Richardson,[...]. Nat Neurosci 2019
89
25

Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.
Sung R Choi, Owain W Howell, Daniele Carassiti, Roberta Magliozzi, Djordje Gveric, Paolo A Muraro, Richard Nicholas, Federico Roncaroli, Richard Reynolds. Brain 2012
205
25

Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial.
Diego Cadavid, Laura Balcer, Steven Galetta, Orhan Aktas, Tjalf Ziemssen, Ludo Vanopdenbosch, Jette Frederiksen, Mark Skeen, Glenn J Jaffe, Helmut Butzkueven,[...]. Lancet Neurol 2017
137
25

The senescence-associated secretory phenotype: the dark side of tumor suppression.
Jean-Philippe Coppé, Pierre-Yves Desprez, Ana Krtolica, Judith Campisi. Annu Rev Pathol 2010
25

Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.
B Kornek, M K Storch, R Weissert, E Wallstroem, A Stefferl, T Olsson, C Linington, M Schmidbauer, H Lassmann. Am J Pathol 2000
678
25

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial.
Diego Cadavid, Michelle Mellion, Raymond Hupperts, Keith R Edwards, Peter A Calabresi, Jelena Drulović, Gavin Giovannoni, Hans-Peter Hartung, Douglas L Arnold, Elizabeth Fisher,[...]. Lancet Neurol 2019
44
25

Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide.
Paul A Felts, Anne-Marie Woolston, Himali B Fernando, Stephen Asquith, Norman A Gregson, Oliver J Mizzi, Kenneth J Smith. Brain 2005
125
25


Defective cholesterol clearance limits remyelination in the aged central nervous system.
Ludovico Cantuti-Castelvetri, Dirk Fitzner, Mar Bosch-Queralt, Marie-Theres Weil, Minhui Su, Paromita Sen, Torben Ruhwedel, Miso Mitkovski, George Trendelenburg, Dieter Lütjohann,[...]. Science 2018
165
25

Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation.
Mark R Kotter, Wen-Wu Li, Chao Zhao, Robin J M Franklin. J Neurosci 2006
436
25

Evidence for a two-stage disability progression in multiple sclerosis.
Emmanuelle Leray, Jacqueline Yaouanq, Emmanuelle Le Page, Marc Coustans, David Laplaud, Joël Oger, Gilles Edan. Brain 2010
343
25

Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis.
Manuel A Friese, Benjamin Schattling, Lars Fugger. Nat Rev Neurol 2014
318
25

Dynamic Imaging of Individual Remyelination Profiles in Multiple Sclerosis.
Benedetta Bodini, Mattia Veronese, Daniel García-Lorenzo, Marco Battaglini, Emilie Poirion, Audrey Chardain, Léorah Freeman, Céline Louapre, Maya Tchikviladze, Caroline Papeix,[...]. Ann Neurol 2016
94
25

iPS-derived neural progenitor cells from PPMS patients reveal defect in myelin injury response.
Alexandra M Nicaise, Erin Banda, Rosa M Guzzo, Kristen Russomanno, Wanda Castro-Borrero, Cory M Willis, Kasey M Johnson, Albert C Lo, Stephen J Crocker. Exp Neurol 2017
33
25

CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination.
Malgorzata Zawadzka, Leanne E Rivers, Stephen P J Fancy, Chao Zhao, Richa Tripathi, Françoise Jamen, Kaylene Young, Alexander Goncharevich, Hartmut Pohl, Matteo Rizzi,[...]. Cell Stem Cell 2010
395
25

FGF modulates the PDGF-driven pathway of oligodendrocyte development.
R D McKinnon, T Matsui, M Dubois-Dalcq, S A Aaronson. Neuron 1990
536
25

Remyelination is extensive in a subset of multiple sclerosis patients.
Peter Patrikios, Christine Stadelmann, Alexandra Kutzelnigg, Helmut Rauschka, Manfred Schmidbauer, Henning Laursen, Per Soelberg Sorensen, Wolfgang Brück, Claudia Lucchinetti, Hans Lassmann. Brain 2006
494
25

The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.
Richard Reynolds, Mary Dawson, Dimitrios Papadopoulos, Annabella Polito, Isabelle Cenci Di Bello, Danielle Pham-Dinh, Joel Levine. J Neurocytol 2002
134
25


Remyelination capacity of the MS brain decreases with disease chronicity.
T Goldschmidt, J Antel, F B König, W Brück, T Kuhlmann. Neurology 2009
233
25

Targeting senescence to delay progression of multiple sclerosis.
Wendy Oost, Nynke Talma, Jan F Meilof, Jon D Laman. J Mol Med (Berl) 2018
19
25

LINGO-1 negatively regulates myelination by oligodendrocytes.
Sha Mi, Robert H Miller, Xinhua Lee, Martin L Scott, Svetlane Shulag-Morskaya, Zhaohui Shao, Jufang Chang, Greg Thill, Melissa Levesque, Mingdi Zhang,[...]. Nat Neurosci 2005
438
25

Fibroblast growth factor signalling in multiple sclerosis: inhibition of myelination and induction of pro-inflammatory environment by FGF9.
Maren Lindner, Katja Thümmler, Ariel Arthur, Sarah Brunner, Christina Elliott, Daniel McElroy, Hema Mohan, Anna Williams, Julia M Edgar, Cornelia Schuh,[...]. Brain 2015
33
25

Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice.
F Ruffini, R Furlan, P L Poliani, E Brambilla, P C Marconi, A Bergami, G Desina, J C Glorioso, G Comi, G Martino. Gene Ther 2001
87
25

Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation.
Lior Mayo, Sunia A Trauger, Manon Blain, Meghan Nadeau, Bonny Patel, Jorge I Alvarez, Ivan D Mascanfroni, Ada Yeste, Pia Kivisäkk, Keith Kallas,[...]. Nat Med 2014
224
25



Ciliary neurotrophic factor (CNTF) enhances myelin formation: a novel role for CNTF and CNTF-related molecules.
Bruno Stankoff, Marie-Stéphane Aigrot, Frédéric Noël, Aurélie Wattilliaux, Bernard Zalc, Catherine Lubetzki. J Neurosci 2002
171
25

Neurotoxic reactive astrocytes are induced by activated microglia.
Shane A Liddelow, Kevin A Guttenplan, Laura E Clarke, Frederick C Bennett, Christopher J Bohlen, Lucas Schirmer, Mariko L Bennett, Alexandra E Münch, Won-Suk Chung, Todd C Peterson,[...]. Nature 2017
25

Astrocyte-derived GDNF is a potent inhibitor of microglial activation.
Sandra Moreira Rocha, Ana Clara Cristovão, Filipa Lopes Campos, Carla Pais Fonseca, Graça Baltazar. Neurobiol Dis 2012
105
25

Astrocyte scar formation aids central nervous system axon regeneration.
Mark A Anderson, Joshua E Burda, Yilong Ren, Yan Ao, Timothy M O'Shea, Riki Kawaguchi, Giovanni Coppola, Baljit S Khakh, Timothy J Deming, Michael V Sofroniew. Nature 2016
817
25

Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS.
Rhonda R Voskuhl, R Scott Peterson, Bingbing Song, Yan Ao, Laurie Beth J Morales, Seema Tiwari-Woodruff, Michael V Sofroniew. J Neurosci 2009
290
25

Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination.
Hema Mohan, Anita Friese, Stefanie Albrecht, Markus Krumbholz, Christina L Elliott, Ariel Arthur, Ramesh Menon, Cinthia Farina, Andreas Junker, Christine Stadelmann,[...]. Acta Neuropathol Commun 2014
26
25

Progressive multiple sclerosis: pathology and pathogenesis.
Hans Lassmann, Jack van Horssen, Don Mahad. Nat Rev Neurol 2012
520
25

Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation.
Stephen A Back, Therese M F Tuohy, Hanqin Chen, Nicholas Wallingford, Andrew Craig, Jaime Struve, Ning Ling Luo, Fatima Banine, Ying Liu, Ansi Chang,[...]. Nat Med 2005
410
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.